Cite

HARVARD Citation

    Lametschwandtner, G. et al. (n.d.). Development of a personalized cellular ex-vivo cbl-b silencing cancer immunotherapy. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record